160 related articles for article (PubMed ID: 31604898)
21. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
22. Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer.
Buehner TM; Liotta M; Potkul RK; Wagner RH; Savir-Baruch B
Mol Imaging Biol; 2024 Feb; 26(1):45-52. PubMed ID: 36754935
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of fluciclovine (
Akin-Akintayo O; Tade F; Mittal P; Moreno C; Nieh PT; Rossi P; Patil D; Halkar R; Fei B; Master V; Jani AB; Kitajima H; Osunkoya AO; Ormenisan-Gherasim C; Goodman MM; Schuster DM
Eur J Radiol; 2018 May; 102():1-8. PubMed ID: 29685521
[TBL] [Abstract][Full Text] [Related]
24. A review discussing fluciclovine (
Zanoni L; Bossert I; Matti A; Schiavina R; Pultrone C; Fanti S; Nanni C
Future Oncol; 2018 May; 14(11):1101-1115. PubMed ID: 29359581
[TBL] [Abstract][Full Text] [Related]
25. Impact of
Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R; Cooper S; Chen Z; Schuster DM
J Nucl Med; 2017 Mar; 58(3):412-418. PubMed ID: 27609792
[TBL] [Abstract][Full Text] [Related]
26. Extraprostatic Uptake of
Robertson MS; Sakellis CG; Hyun H; Jacene HA
AJR Am J Roentgenol; 2020 Mar; 214(3):641-648. PubMed ID: 31939697
[No Abstract] [Full Text] [Related]
27. 18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.
Nanni C; Schiavina R; Brunocilla E; Boschi S; Borghesi M; Zanoni L; Pettinato C; Martorana G; Fanti S
Clin Nucl Med; 2015 Aug; 40(8):e386-91. PubMed ID: 26053708
[TBL] [Abstract][Full Text] [Related]
28.
Selnæs KM; Krüger-Stokke B; Elschot M; Willoch F; Størkersen Ø; Sandsmark E; Moestue SA; Tessem MB; Halvorsen D; Kjøbli E; Angelsen A; Langørgen S; Bertilsson H; Bathen TF
Eur Radiol; 2018 Aug; 28(8):3151-3159. PubMed ID: 29294158
[TBL] [Abstract][Full Text] [Related]
29.
Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo OO; Tade FI; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM; Fei B; Schuster DM
J Nucl Med; 2019 Nov; 60(11):1531-1536. PubMed ID: 30954940
[TBL] [Abstract][Full Text] [Related]
30. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
[TBL] [Abstract][Full Text] [Related]
31. Effect of
Scarsbrook AF; Bottomley D; Teoh EJ; Bradley KM; Payne H; Afaq A; Bomanji J; van As N; Chua S; Hoskin P; Chambers A; Cook GJ; Warbey VS; Han S; Leung HY; Chau A; Miller MP; Gleeson FV;
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):316-324. PubMed ID: 32068113
[TBL] [Abstract][Full Text] [Related]
32. Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer.
Farkas AB; Green ED; Thaggard AL; Vijayakumar V; Henegan JC; Lirette ST; Nittala MR; Vijayakumar S
South Med J; 2021 Nov; 114(11):703-707. PubMed ID: 34729614
[TBL] [Abstract][Full Text] [Related]
33.
Seierstad T; Hole KH; Tulipan AJ; Strømme H; Lilleby W; Revheim ME; Hernes E
PET Clin; 2021 Apr; 16(2):167-176. PubMed ID: 33648662
[TBL] [Abstract][Full Text] [Related]
34. Prospective Clinical Trial of
Ulaner GA; Goldman DA; Corben A; Lyashchenko SK; Gönen M; Lewis JS; Dickler M
J Nucl Med; 2017 Jul; 58(7):1037-1042. PubMed ID: 27856630
[No Abstract] [Full Text] [Related]
35. [
Alemozaffar M; Akintayo AA; Abiodun-Ojo OA; Patil D; Saeed F; Huang Y; Osunkoya AO; Goodman MM; Sanda M; Schuster DM
J Urol; 2020 Oct; 204(4):734-740. PubMed ID: 32347780
[TBL] [Abstract][Full Text] [Related]
36. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.
Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM
J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619
[TBL] [Abstract][Full Text] [Related]
37.
Jani AB; Schreibmann E; Goyal S; Halkar R; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M; Master VA; Joshi SS; Kucuk O; Carthon BC; Bilen MA; Abiodun-Ojo OA; Akintayo AA; Dhere VR; Schuster DM
Lancet; 2021 May; 397(10288):1895-1904. PubMed ID: 33971152
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.
Chau A; Gardiner P; Colletti PM; Jadvar H
Clin Nucl Med; 2018 Jul; 43(7):e226-e231. PubMed ID: 29762238
[TBL] [Abstract][Full Text] [Related]
39.
Rais-Bahrami S; Efstathiou JA; Turnbull CM; Camper SB; Kenwright A; Schuster DM; Scarsbrook AF
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):997-1006. PubMed ID: 34012062
[TBL] [Abstract][Full Text] [Related]
40. Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer.
Sörensen J; Owenius R; Lax M; Johansson S
Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):394-402. PubMed ID: 23208700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
